Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to CHECKPOINT INHIBITORS

Hematology, ASH Education Program

Treatment of CML in Pregnancy

Hematology December 19th 2022

Oncology News Central (ONC)

Alpine Stops Enrollment in Cancer Drug Study After Second Patient Death This Year

Cardiology November 7th 2022

Cancer Therapy Advisor

Poor Outcomes Seen in Advanced Cancer Patients Treated with Inpatient ICI Therapy

Hematology/Oncology October 31st 2022

Journal of Clinical Oncology

Adjuvant Therapy of Nivolumab Combined with Ipilimumab vs. Nivolumab Alone in Patients with Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)

Oncology, Medical October 3rd 2022

MedPage Today

ASCO Addresses PARP Controversy in Guideline Update

Oncology, Medical October 3rd 2022

Journal of Clinical Oncology

Poly(ADP-Ribose) Polymerase (PARP) Inhibitors in the Management of Ovarian Cancer: ASCO Guideline Rapid Recommendation Update

Oncology, Medical October 3rd 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form